Search results
Sanofi reports findings from Phase II relapsing MS treatment trial
Clinical Trials Arena· 2 days agoSanofi has reported the latest data from a Phase II clinical trial of a cluster of differentiation...
Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says - ET HealthWorld | Pharma
The Economic Times· 2 days agoThe paper cited German government sources as saying Sanofi changed course after initial...
Sanofi India - Closure of Trading Window
CNBC Awaaz· 1 day agoSanofi India - Closure of Trading Window
Sanofi reports data from Phase II demyelinating polyneuropathy trial
Clinical Trials Arena· 6 days agoSanofi has reported one-year follow-up findings from an ongoing Phase II clinical trial of its...
Sanofi reports positive data from Phase III EoE treatment trial
Clinical Trials Arena· 6 days agoSanofi has announced the publication of positive results from a Phase III clinical trial of Dupixent...
Sanofi-backed Formation Bio raises $372 million in late-stage funding round - ET HealthWorld |...
The Economic Times· 6 days agoLondon: AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker
Pharma companies shape competitive pipeline for bronchiectasis
Clinical Trials Arena· 6 hours agoPharmaceutical companies involved in the field of bronchiectasis include Insmed, Boehringer...
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge
Hindustan Times· 23 hours agoThe ruling by Judge Vivian Medinilla of the Delaware Superior Court means that the drugmakers, which...
Emcure planning acquisition, in-licensing deals
Financial Express· 4 days agoEmcure Pharmaceuticals upcoming initial public offering (IPO) wil give the company access to new growth capital which it will use to fund inorganic...
Pharma M&A: The top high value deals in 2023
Pharmaceutical Technology· 7 days agoFrom Pfizer’s Seagen acquisition to Sanofi’s deal with Provention Bio, Pharmaceutical Technology lists the highest value pharma mergers and acquisitions...